Skip to main content

Nasdaq ETFs

Guardant Health Reaches Analyst Target Price

5 years 10 months ago
In recent trading, shares of Guardant Health Inc (Symbol: GH) have crossed above the average analyst 12-month target price of $122.57, changing hands for $123.65/share. When a stock reaches the target an analyst has set, the analyst logically has two ways to react: downgrade on

FOLD Crosses Above Average Analyst Target

5 years 10 months ago
In recent trading, shares of Amicus Therapeutics Inc (Symbol: FOLD) have crossed above the average analyst 12-month target price of $22.28, changing hands for $23.18/share. When a stock reaches the target an analyst has set, the analyst logically has two ways to react: downgrade

DDOG Crosses Above Average Analyst Target

5 years 10 months ago
In recent trading, shares of Datadog Inc (Symbol: DDOG) have crossed above the average analyst 12-month target price of $99.78, changing hands for $101.57/share. When a stock reaches the target an analyst has set, the analyst logically has two ways to react: downgrade on valuati

Caesars Entertainment Reaches Analyst Target Price

5 years 10 months ago
In recent trading, shares of Caesars Entertainment Inc (Symbol: CZR) have crossed above the average analyst 12-month target price of $73.00, changing hands for $73.84/share. When a stock reaches the target an analyst has set, the analyst logically has two ways to react: downgra

ACIW Crosses Above Average Analyst Target

5 years 10 months ago
In recent trading, shares of ACI Worldwide Inc (Symbol: ACIW) have crossed above the average analyst 12-month target price of $38.50, changing hands for $38.84/share. When a stock reaches the target an analyst has set, the analyst logically has two ways to react: downgrade on va

5 Leveraged ETFs That Gained At Least 10% Last Week

5 years 10 months ago
The S&P 500, the Dow Jones and the Nasdaq Composite gained about 1.7%, 1.0% and 2.1%, respectively, last week. All three indexes touched all-time closing highs to end last week, despite the downbeat jobs and manufacturing report. The small-cap index Russell 2000 was also up 2

4 Sector ETFs Looking Solid Amid Soft November Jobs Data

5 years 10 months ago
The U.S. economy added 245,000 jobs in November, heavily easing from a downwardly revised 610,000 in October, and considerably below market expectations of 469,000. It represented the smallest employment gain since the labor market recovery which started in May.

VALE Crosses Above Average Analyst Target

5 years 10 months ago
In recent trading, shares of Vale SA (Symbol: VALE) have crossed above the average analyst 12-month target price of $15.75, changing hands for $16.05/share. When a stock reaches the target an analyst has set, the analyst logically has two ways to react: downgrade on valuation, o

TDG Crosses Above Average Analyst Target

5 years 10 months ago
In recent trading, shares of TransDigm Group Inc (Symbol: TDG) have crossed above the average analyst 12-month target price of $602.58, changing hands for $605.67/share. When a stock reaches the target an analyst has set, the analyst logically has two ways to react: downgrade on

OSB Crosses Above Average Analyst Target

5 years 10 months ago
In recent trading, shares of Norbord Inc (Symbol: OSB) have crossed above the average analyst 12-month target price of $41.92, changing hands for $41.96/share. When a stock reaches the target an analyst has set, the analyst logically has two ways to react: downgrade on valuation

HPE Crosses Above Average Analyst Target

5 years 10 months ago
In recent trading, shares of Hewlett Packard Enterprise Co (Symbol: HPE) have crossed above the average analyst 12-month target price of $12.29, changing hands for $12.34/share. When a stock reaches the target an analyst has set, the analyst logically has two ways to react: down

NOV Crosses Above Average Analyst Target

5 years 10 months ago
In recent trading, shares of National Oilwell Varco Inc (Symbol: NOV) have crossed above the average analyst 12-month target price of $14.08, changing hands for $14.55/share. When a stock reaches the target an analyst has set, the analyst logically has two ways to react: downgra

Boyd Gaming Reaches Analyst Target Price

5 years 10 months ago
In recent trading, shares of Boyd Gaming Corp. (Symbol: BYD) have crossed above the average analyst 12-month target price of $42.00, changing hands for $42.30/share. When a stock reaches the target an analyst has set, the analyst logically has two ways to react: downgrade on val

Turkey Inflation – Back with a Vengeance

5 years 10 months ago
By Natalia Gurushina, Chief Economist, Emerging Markets Fixed Income Strategy, VanEck A surprising increase in Turkish inflation will test the central bank’s recent policy U-turn. Brazil’s Q3 rebound was weaker than expected, raising more questions about the country’s ability to grow out of debt. A sizable upside surprise in Turkey’s inflation (14.03% year-on-year in November) means a sizable [...] Read more at ETFtrends.com.

A Turning Point for Emerging Markets

5 years 10 months ago
By Matt Wagner, CFA, Senior Research Analyst, WisdomTree Positive developments for vaccines offer hope for the ultimate reopening of the global economy in 2021 and are causing many to look for the much-awaited “rotation” into value strategies. In one example of this value rotation, emerging market equities have outperformed the U.S. by more than 600 basis points (bps) since [...] Read more at ETFtrends.com.

November ETF Flows: Getting Closer to the End of the Tunnel

5 years 10 months ago
By Matthew J Bartolini, Head of SPDR Americas Research, CFA, State Street Investors deposited $90+ billion into ETFs last month, with $81 billion going to equity funds Sector-focused ETFs posted strong monthly inflows, largely driven by cyclicals Flows into funds focused on innovative trends took in $7 billion The market breathed a heavy sigh of relief [...] Read more at ETFtrends.com.

A New Reality?

5 years 10 months ago
By Salvatore J. Bruno, Chief Investment Officer, Managing Director, IndexIQ Just like that, it seems, we’re in a new reality, one in which there’s not just one, not two but three highly effective vaccines for limiting the spread of COVID-19 and saving lives. Pharmaceutical companies Pfizer (with partner BioNTech), Moderna, and now Astra-Oxford have all announced trial [...] Read more at ETFtrends.com.
Checked
9 minutes 32 seconds ago
This feed is responsible for generating the rss feed related to the topic ETFs
Subscribe to Nasdaq ETFs feed